Global Vascular Access Device Market

1 INTRODUCTION OF GLOBAL VASCULAR ACCESS DEVICES MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL VASCULAR ACCESS DEVICES MARKET OUTLOOK
4.1 Overview

4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities

4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL VASCULAR ACCESS DEVICES MARKET, BY TYPE
5.1 Central Vascular Access Devices
5.1.1 Peripherally Inserted Central Catheters
5.1.2 Tunneled Catheters
5.1.3 Non-Tunneled Catheters
5.1.4 Implanted Ports

5.2 Peripheral Vascular Access Devices
5.3 Peripheral Short Devices
5.4 Peripheral Midline Devices
5.5 Butterfly/Winged Steel Needles
5.6 Accessories

6 GLOBAL VASCULAR ACCESS DEVICES MARKET, BY END USER
6.1 Hospitals
6.2 Clinical and ambulatory care centers
6.3 Others

7 GLOBAL VASCULAR ACCESS DEVICES MARKET, BY APPLICATION
7.1 Drug Administration
7.2 Fluid and Nutrition Administration
7.3 Blood Transfusion
7.4 Diagnostics and Testing

8 GLOBAL VASCULAR ACCESS DEVICES MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

9 GLOBAL VASCULAR ACCESS DEVICES MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Becton, Dickinson and Company
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 C.R.Bard, Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Teleflex Incorporated
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Smiths Medical, Inc.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 B Braun Melsungen AG
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Angiodynamics
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Terumo Corporation
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Nipro Medical Corporation
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Edwards Lifesciences Corporation
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Ameco Medical
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Romsons Scientific & Surgical Pvt. Ltd.
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments

10.12 Prodimed
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments

11 Appendix
11.1 Related Reports